Cerapedics i-FACTOR: An alternative to autograft? 3 key points

Spinal Tech

A new study shows the Cerapedics i-FACTOR biologic bone graft could be an alterative to autograft during spine surgery.

The i-FACTOR is a biologic bone graft used in posterior lumbar interbody fusion. "This study suggests that i-FACTOR biologic bone graft may have equal or greater efficacy at six and 12 months following PLIF procedures, and pain and functional improvements exceed success criteria," said Dr. Philippe Lauweryns, an orthopedic surgeon in Belgium.

 

Here are three key notes on the study:

 

1. There were 40 patients involved and after six months, intra-cage bridging bone occurred in 98 percent of the i-FACTOR patients; the same was true for only 59 percent of the local autograft patients.

 

2. The pain scores decreased 29 points among the patients and function improved 43 points on average.

 

3. The i-FACTOR biologic bone graft includes synthetic small peptide technology to support bone growth through cell attachment and osteoblast differentiation.

 

"The use of autologous bone grafts in spinal fusion procedures has meaningful limitations including lack of availability of adequate volumes and quality of locally harvested bone," said Cerapedics CEO Glen Kashuba. "While harvesting of autologous iliac crest bone can overcome these limitations, it creates the potential for complications including chronic pain and infection."

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Podcast

Featured Whitepapers